Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly (NYSE: LLY). But now, an investment in ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 16.04%, which has investors questioning if this is right time to ...

Viking Therapeutics, Inc.’s VKTX share price has surged by 5.65%, which has investors questioning if this is right time to ...

Glucagon-like peptide-1, it is probably best described as a post-nutrient hormone. What does that mean ... There's little doubt that, look, for most people regular exercise and just eating ...

Lilly trumpeted positive topline results from ACHIEVE-1 (NCT05971940) showing orforglipron to have met the trial’s primary ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

WEIGHT loss injections have become the holy grail in the fight against obesity, helping people shift the pounds they’ve been ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...

If Lilly does wind up facing these challenges ... the blockbuster drugs Mounjaro and Zepbound. These are Lilly's glucagon-like peptide-1 (GLP-1) medicines, which compete directly with Novo ...

My dad, Michael Mosley, was an inspiration to millions of people worldwide – particularly those living with obesity or type 2 ...